The field of anticoagulation has undergone a profound transformation with the introduction of Factor Xa inhibitors, fundamentally changing how healthcare professionals approach the prevention and treatment of thrombotic disorders. This class of medications, including apixaban, offers a streamlined approach compared to older therapies, reducing the need for constant patient monitoring and...